Published in
Elsevier, Clinical Genitourinary Cancer, 3(19), p. e171-e177, 2021
DOI: 10.1016/j.clgc.2020.12.008
Links
Tools
Neutropenia prevention in the treatment of post-docetaxel metastatic, castration-resistant prostate cancer with cabazitaxel and prednisone: a multicenter, open-label, single-arm phase IV study
Journal article published in 2021 by
Fernando C. Maluf 
,
Fabrício A. M. de Oliveira,
Pedro E. R. Liedke,
Leandro Brust,
Cristina G. Inocêncio,
Fernando S. M. Monteiro ,
Oren Smaletz ,
Daniel I. Cubero
,
Fabrício A. M. de Oliveira,
Pedro E. R. Liedke,
Leandro Brust,
Cristina G. Inocêncio,
Fernando S. M. Monteiro ,
Oren Smaletz ,
Daniel I. Cubero
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 